Coronary Arteriosclerosis: Clinical Trials

18 trials for Coronary Arteriosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 2 terminated, 2 unknown. 18 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 318Completed 14, Terminated 2, Unknown 2
Phase 21Completed 1

Follow Coronary Arteriosclerosis: new trials by email Literature Review of Coronary Arteriosclerosis trials Research Report on Coronary Arteriosclerosis

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
68Ga-DOTATATE PET-CTA Imaging for the Early Detection of Progressing Coronary Atherosclerosis
injection of 68Ga-DOTATATE - Coronary Arteriosclerosis
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris122019-11-212022-06-30
Does Omega-3 Polyunsaturated Fatty Acids (PUFAs) Pretreatment Improve Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI)?
omega 3 - Coronary Arteriosclerosis
Phase 3UnknownShiraz University of Medical Sciences902012-02-012013-01-29
Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)
omega 3 - Coronary Arteriosclerosis
Phase 3CompletedShahid Beheshti University of Medical Sciences1042012-01-012012-12-10
Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device
Manual Compression, Vascular Closure Device - Angioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis
Phase 3CompletedCordis US Corp.4882007-02-012012-06-01
Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent
Percutaneous coronary intervention with Taxus stent - Coronary Arteriosclerosis
Phase 3CompletedFrench Cardiology Society1552005-12-012011-01-04
A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention
Prasugrel, Clopidogrel - Coronary Arteriosclerosis, Acute Coronary Syndromes
Phase 3CompletedEli Lilly and Company136192004-11-012010-09-16
Estrogen, HDL, and Coronary Heart Disease in Women
Estrogens, Conjugated (USP), Medroxyprogesterone 17-Acetate, Placebo - Cardiovascular Diseases, Coronary Disease
Phase 2 / Phase 3CompletedTufts University3092004-03-012016-04-21
A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
torcetrapib/atorvastatin, atorvastatin - Coronary Disease, Coronary Arteriosclerosis
Phase 3CompletedPfizer11002003-10-012007-12-10
Cleansing of Suction Blood in Cardiac Surgery for Reduced Inflammatory Response
Cell saver, No cell saver - Systemic Inflammatory Response Syndrome, Coronary Arteriosclerosis
Phase 3TerminatedCopenhagen University Hospital, Rigshospitalet302003-01-012008-01-14
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
Rosuvastatin calcium - Coronary Arteriosclerosis
Phase 3CompletedAstraZeneca4502002-11-012010-11-19
Copenhagen Arterial Revascularization Randomized Patency and Outcome Trial
Total arterial revascularization, Conventional revascularization - Coronary Arteriosclerosis, Ischemic Heart Disease
Phase 3UnknownCopenhagen University Hospital, Rigshospitalet3312002-02-012008-02-15
Radial Artery Versus Saphenous Vein Patency (RSVP) Study
Coronary artery bypass graft (CABG) surgery - Coronary Arteriosclerosis
Phase 3CompletedImperial College London1421998-05-012019-06-25
Women's Angiographic Vitamin and Estrogen Trial (WAVE)
estrogen replacement therapy, estrogens, conjugated, progesterone - Cardiovascular Diseases, Coronary Arteriosclerosis
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1996-08-012016-07-12
Estrogen and Graft Atherosclerosis Research Trial (EAGER)
hormone replacement therapy, estrogens, medroxyprogesterone - Cardiovascular Diseases, Coronary Arteriosclerosis
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1996-08-012016-02-18
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
estrogen replacement therapy, hormone replacement therapy, estrogens - Cardiovascular Diseases, Coronary Arteriosclerosis
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1994-08-012016-03-16
Familial Atherosclerosis Treatment Study
lovastatin, colestipol, niacin - Cardiovascular Diseases, Coronary Arteriosclerosis
Phase 3CompletedUniversity of Washington1461984-01-012015-12-03
Stanford Coronary Risk Intervention Project (SCRIP)
smoking cessation, diet, reducing, exercise - Cardiovascular Diseases, Coronary Arteriosclerosis
Phase 3CompletedStanford University1983-09-012016-01-12
Cholesterol-Lowering Atherosclerosis Study (CLAS)
colestipol, niacin, diet, fat-restricted - Arterial Occlusive Diseases, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1980-06-012013-12-13

Narrower conditions

Coronary Artery Disease (18)  ·  Coronary Disease (8)  ·  Cardiovascular Diseases (7)  ·  Heart Diseases (7)  ·  Myocardial Ischemia (7)  ·  Atherosclerosis (2)  ·  Acute Coronary Syndrome (1)  ·  Angina Pectoris (1)  ·  Arterial Occlusive Diseases (1)  ·  Carotid Artery Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Hyperlipidemias (1)  ·  Intracranial Arteriosclerosis (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Arteriosclerosis (18)  ·  Vascular Diseases (18)  ·  Arterial Occlusive Diseases (17)  ·  Cardiovascular Diseases (11)  ·  Heart Diseases (11)  ·  Myocardial Ischemia (11)  ·  Coronary Disease (10)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chest Pain (1)  ·  Dyslipidemias (1)  ·  Inflammation (1)  ·  Intracranial Arterial Diseases (1)  ·  Lipid Metabolism Disorders (1)

Interventions

Hormone Replacement Therapy (3)  ·  Colestipol (2)  ·  Diet, Fat-Restricted (2)  ·  Docosahexaenoic Acids (2)  ·  Estrogen Replacement Therapy (2)  ·  Estrogens (2)  ·  Estrogens, Conjugated (USP) (2)  ·  Fish Oils (2)  ·  Niacin (2)  ·  Ascorbic Acid (1)  ·  Atorvastatin (1)  ·  Clopidogrel (1)  ·  Coronary Artery Bypass (1)  ·  Diet, Reducing (1)  ·  Dietary Supplements (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (4)  ·  Copenhagen University Hospital, Rigshospitalet (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  AstraZeneca (1)  ·  Cordis US Corp. (1)  ·  Eli Lilly and Company (1)  ·  French Cardiology Society (1)  ·  Imperial College London (1)  ·  Pfizer (1)  ·  Shahid Beheshti University of Medical Sciences (1)  ·  Shiraz University of Medical Sciences (1)  ·  Stanford University (1)  ·  Tufts University (1)  ·  University of Washington (1)

Countries

United States (5)  ·  France (3)  ·  Belgium (2)  ·  Canada (2)  ·  Denmark (2)  ·  Iran (2)  ·  Netherlands (2)  ·  Spain (2)  ·  Australia (1)  ·  Italy (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Sune Damgaard, MD (2)  ·  B. Greg Brown, M.D., Ph.D (1)  ·  David Blankenhorn (1)  ·  David Herrington (1)  ·  David M Herrington, MD (1)  ·  Edwin Alderman (1)  ·  Jamshid Salamzadeh, PhD (1)

Results publications

PMID 16533939, PMID 16722590, PMID 17387129, PMID 17982182, PMID 18174456, PMID 18377975, PMID 18498956, PMID 18506009, PMID 18757948, PMID 19029466, PMID 19106084, PMID 19155011, PMID 19249633, PMID 19270315, PMID 19489872, PMID 19695549, PMID 19699846, PMID 20026770, PMID 20580029, PMID 20713903, PMID 20723851, PMID 21606391, PMID 22199016, PMID 22633653, PMID 22995726, PMID 23134549, PMID 24140678, PMID 24947719, PMID 30975005, PMID 32164882, PMID 35224730

NIH funding

2017 (1), N01HV68165 (1), N01HV68166 (1), N01HV68167 (1), N01HV68168 (1), N01HV68169 (1), N01HV68170 (1), P01HL023619 (1), P01HL030086 (1), R01HL028292 (1), R01HL070081 (1), U01HL049488 (1), U01HL050840 (1)